SCTbio

Prague, Czech Republic
CAR-T Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
81.6
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (5) ○ MHRA GMP

Quick Facts: SCTbio

Signal Score
81.6/100 (as of 2026-04-29)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Prague, Czech Republic
Modalities
CAR-T, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About SCTbio

Pure-play cell therapy CDMO. Part of PPF Biotech network.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates5 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: PPF Group
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: PPF Group
Financial assessment: 68.0/100
Capacity 63.0
2 manufacturing sites
Sites: Prague, Czech Republic, Boston, MA
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites

SCTbio EMA GMP Compliance 5 certificates

2026-03
2026-03
2024-01
2023-11
2022-07
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
sukls420762/2025 SCT Cell Manufacturing s.r.o. Czechia 2026-03-19 COMPLIANT
sukls420756/2025 SCT Cell Manufacturing s.r.o. Czechia 2026-03-18 COMPLIANT
sukls261199/2023 SCT Cell Manufacturing s.r.o. Czechia 2024-01-15 COMPLIANT
sukls261141/2023 SCT Cell Manufacturing s.r.o. Czechia 2023-11-30 COMPLIANT
sukls139841/2022 SCT Cell Manufacturing s.r.o. Czechia 2022-07-14 COMPLIANT
Source: EMA EudraGMDP · Retrieved Jul 04, 2026

Frequently Asked Questions About SCTbio

Does SCTbio hold EMA or MHRA GMP certificates?
CDMO Signal tracks 5 EMA GMP certificates for SCTbio.
What is SCTbio's CDMO Signal Score?
SCTbio has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating SCTbio for a manufacturing program?
Use the free AI matchmaker to compare SCTbio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.8
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 83.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy